Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C-Reference-Cited by-同舟云学术

Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C

Published:2019-02-11 Issue:2 Volume:14 Page:e0212036
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hansen Janne Fuglsang^ORCID,Christiansen Karen Mølgaard,Staugaard Benjamin,Moessner Belinda Klemmensen,Lillevang Søren^ORCID,Krag Aleksander,Christensen Peer Brehm

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C;DT Lau;Hepatology,1998

2. Noninvasive Assessment of Liver Fibrosis;L Castera;Dig Dis,2015

3. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C;J Vergniol;Gastroenterology,2011

4. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C;J Vergniol;Hepatology,2014

5. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus;V de Ledinghen;Aliment Pharmacol Ther,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats;International Journal of Molecular Sciences;2023-02-14

2. Polymeric nanomaterial strategies to encapsulate and deliver biological drugs: points to consider between methods;Biomaterials Science;2023

3. Diagnostic Accuracy of Red Cell Distribution Width to Platelet Ratio for Detection of Liver Fibrosis Compared with Fibroscan in Chronic Hepatitis B Egyptian patients;The Open Biomarkers Journal;2022-10-12

4. Densification: Hyaluronan Aggregation in Different Human Organs;Bioengineering;2022-04-05

5. Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus;PLOS ONE;2022-01-12